Bioservo Technologies AB Interim Report January - March 2020
First quarter in figures · Net sales of SEK 3.0 M (1.7) · EBITDA of SEK -6.6 M (-4.4) · EBIT of SEK -7.5 M (-5.4) · Earnings for the period amounted to SEK -7.5 M (-5.4) · Earnings per share before and after dilution amounted to SEK -0.53 (-0.60) · Cash flow from operating activities for the period amounted to SEK -6.2 M (-8.3) · At 31 March, cash and cash equivalents were SEK 50.3 M (17.3) Significant events during the period Launch of a new version of Ironhand®, the latest active soft exoskeleton from Bioservo Technologies that further optimizes the user